Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

A Pharmacogenetic Determinant of Mu-Opioid Receptor Antagonist Effects on Alcohol Reward and Consumption: Evidence from Humanized Mice.

Bilbao A, Robinson JE, Heilig M, Malanga CJ, Spanagel R, Sommer WH, Thorsell A.

Biol Psychiatry. 2014 Sep 8. pii: S0006-3223(14)00653-2. doi: 10.1016/j.biopsych.2014.08.021. [Epub ahead of print]

PMID:
25442002
2.

The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo.

White KL, Robinson JE, Zhu H, DiBerto JF, Polepally PR, Zjawiony JK, Nichols DE, Malanga CJ, Roth BL.

J Pharmacol Exp Ther. 2015 Jan;352(1):98-109. doi: 10.1124/jpet.114.216820. Epub 2014 Oct 15.

PMID:
25320048
3.

Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J mice.

Fish EW, DiBerto JF, Krouse MC, Robinson JE, Malanga CJ.

J Pharmacol Exp Ther. 2014 Aug;350(2):322-9. doi: 10.1124/jpet.114.216135. Epub 2014 Jun 10.

PMID:
24917543
4.

Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice.

Fish EW, Whitman BJ, DiBerto JF, Robinson JE, Morrow AL, Malanga CJ.

Psychopharmacology (Berl). 2014 Sep;231(17):3415-23. doi: 10.1007/s00213-014-3600-8. Epub 2014 May 9.

PMID:
24810108
5.

Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Fish EW, Agoglia AE, Krouse MC, Muller RG, Robinson JE, Malanga CJ.

Behav Pharmacol. 2014 Feb;25(1):61-70. doi: 10.1097/FBP.0000000000000019.

6.

Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome.

Fish EW, Krouse MC, Stringfield SJ, Diberto JF, Robinson JE, Malanga CJ.

PLoS One. 2013 Oct 18;8(10):e77896. doi: 10.1371/journal.pone.0077896. eCollection 2013.

7.

Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice.

Robinson JE, Chen M, Stamatakis AM, Krouse MC, Howard EC, Faccidomo S, Hodge CW, Fish EW, Malanga CJ.

Neuropsychopharmacology. 2013 Jun;38(7):1322-33. doi: 10.1038/npp.2013.30. Epub 2013 Jan 25.

8.

Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome.

Riday TT, Dankoski EC, Krouse MC, Fish EW, Walsh PL, Han JE, Hodge CW, Wightman RM, Philpot BD, Malanga CJ.

J Clin Invest. 2012 Dec;122(12):4544-54. doi: 10.1172/JCI61888. Epub 2012 Nov 12.

9.

Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine.

Robinson JE, Agoglia AE, Fish EW, Krouse MC, Malanga CJ.

Behav Brain Res. 2012 Sep 1;234(1):76-81. doi: 10.1016/j.bbr.2012.06.012. Epub 2012 Jun 21.

10.

The rewarding and locomotor-sensitizing effects of repeated cocaine administration are distinct and separable in mice.

Riday TT, Kosofsky BE, Malanga CJ.

Neuropharmacology. 2012 Mar;62(4):1858-66. doi: 10.1016/j.neuropharm.2011.12.011. Epub 2011 Dec 16.

11.

Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.

Riday TT, Fish EW, Robinson JE, Jarrett TM, McGuigan MM, Malanga CJ.

Brain Res. 2012 Jan 11;1431:53-61. doi: 10.1016/j.brainres.2011.11.003. Epub 2011 Nov 7.

12.

Intracranial self-stimulation in FAST and SLOW mice: effects of alcohol and cocaine.

Fish EW, Robinson JE, Krouse MC, Hodge CW, Reed C, Phillips TJ, Malanga CJ.

Psychopharmacology (Berl). 2012 Apr;220(4):719-30. doi: 10.1007/s00213-011-2523-x. Epub 2011 Oct 7.

13.

Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism.

Robinson JE, Fish EW, Krouse MC, Thorsell A, Heilig M, Malanga CJ.

Psychopharmacology (Berl). 2012 Mar;220(1):215-24. doi: 10.1007/s00213-011-2469-z. Epub 2011 Sep 10.

14.

Definition and classification of hyperkinetic movements in childhood.

Sanger TD, Chen D, Fehlings DL, Hallett M, Lang AE, Mink JW, Singer HS, Alter K, Ben-Pazi H, Butler EE, Chen R, Collins A, Dayanidhi S, Forssberg H, Fowler E, Gilbert DL, Gorman SL, Gormley ME Jr, Jinnah HA, Kornblau B, Krosschell KJ, Lehman RK, MacKinnon C, Malanga CJ, Mesterman R, Michaels MB, Pearson TS, Rose J, Russman BS, Sternad D, Swoboda KJ, Valero-Cuevas F.

Mov Disord. 2010 Aug 15;25(11):1538-49. doi: 10.1002/mds.23088. Review.

15.

Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation.

Timmermann L, Pauls KA, Wieland K, Jech R, Kurlemann G, Sharma N, Gill SS, Haenggeli CA, Hayflick SJ, Hogarth P, Leenders KL, Limousin P, Malanga CJ, Moro E, Ostrem JL, Revilla FJ, Santens P, Schnitzler A, Tisch S, Valldeoriola F, Vesper J, Volkmann J, Woitalla D, Peker S.

Brain. 2010 Mar;133(Pt 3):701-12. doi: 10.1093/brain/awq022. Epub 2010 Mar 5.

16.

Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice.

Fish EW, Riday TT, McGuigan MM, Faccidomo S, Hodge CW, Malanga CJ.

Alcohol Clin Exp Res. 2010 Jan;34(1):81-9. doi: 10.1111/j.1530-0277.2009.01069.x. Epub 2009 Oct 23.

PMID:
19860803
17.

Still no time for complacency: Developmental effects of prenatal methamphetamine exposure.

Malanga CJ.

Neurology. 2009 Jun 16;72(24):2062-3. doi: 10.1212/WNL.0b013e3181a92c98. Epub 2009 Apr 29. No abstract available.

PMID:
19403882
18.

Augmentation of cocaine-sensitized dopamine release in the nucleus accumbens of adult mice following prenatal cocaine exposure.

Malanga CJ, Ren JQ, Guerriero RM, Kosofsky BE.

Dev Neurosci. 2009;31(1-2):76-89. doi: 10.1159/000207496. Epub 2009 Apr 17.

PMID:
19372689
19.

Prenatal exposure to cocaine alters the development of conditioned place-preference to cocaine in adult mice.

Malanga CJ, Pejchal M, Kosofsky BE.

Pharmacol Biochem Behav. 2007 Oct;87(4):462-71. Epub 2007 Jun 21.

20.

Prenatal exposure to cocaine increases the rewarding potency of cocaine and selective dopaminergic agonists in adult mice.

Malanga CJ, Riday TT, Carlezon WA Jr, Kosofsky BE.

Biol Psychiatry. 2008 Jan 15;63(2):214-21. Epub 2007 Jun 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk